HAPLN2 and Parkinson disease: The oligodendrocyte marker Hapln2 (adjusted P = 2.96 × 10−66 and 2.18 × 10−79 in MNPQ and control samples, respectively) promotes α-synuclein aggregation and may contribute to neurodegeneration in PD [46,47].